MarinePro® is an Omega-3 formula sourced from krill, which are tiny crustaceans that live in the Southern Ocean. They are one of the cleanest organisms in the ocean and their lifespan is only one year. They feed on algae rich in Omega-3 and astaxanthin, an antioxidant with a capacity of absorption 400 times stronger than vitamin E.
Most fish oils have other types of fats, and their absorption is limited because many of the amount of long-chain fatty acids. Krill oil, however, is made of phospholipids, a different type of fats, which are easily absorbed. A smaller dose of MarinePro® is more effective in achieving blood levels of Omega-3. The fatty acids of phospholipids are also Omega-3.
It has been shown that the ability to lower bad cholesterol and promote good cholesterol of the fatty acids in krill oil is higher than common fish oil. However, the most important property that krill oil has over ordinary Omega-3 supplements is that astaxanthin, a carotene commonly present in this type of shrimp, has about 48 times more antioxidant strength than common fish oil. Astaxanthin is a particularly healthy antioxidant because, unlike others, is able to cross the blood-brain barrier, and has a protective effect on the brain that, in turn, extends throughout the body. Among other things, astaxanthin supports the immune system, helping to fight free radicals, cell-damaging toxins that cause ageing. It also has protective effects on the eyes, and due to its content of EPA and DHA, it helps control inflammatory processes of the skin, among others.
• Helps improve and control blood cholesterol levels.
4 capsules daily, 2 in the morning and 2 in the evening, before meals. Best combined with Polymatrix® for best results on inflammatory processes.
120 capsules, each containing 750 mg.
|Amount per capsule|
|SuperBa Krill Oil||500 mg|
|Omega-3 fatty acids (ω3)||110 mg|
|EPA (eicosapentainoic acid)||60 mg|
|DHA (docosahexaenoic acid)||38 mg|
|OA (oleic acid ω9)||40 mg|
|GLA (gamma linolenic acid ω6)||5 mg|
Interest on polyunsaturated fatty acids (Omega-3) has increased in recent years, as its numerous potential health benefits have been known. Currently, the ratio of Omega-6 to Omega-3 is increasing in industrialized societies, as a result of increased consumption of vegetable oils rich in Omega-6 fatty acids and low consumption of foods rich in Omega-3(1).
Epidemiological studies results show a negative correlation between the intake of Omega-3 fatty acids and mortality from cardiovascular diseases(2).
The effect of Omega-3 fatty acids is related to the length of their chain, and the protective effects are observed mainly on eicosapentaenoic acid (EPA, 20:5, n-3) and docosahexaenoic acid (DHA, 22:6, n-3). EPA and DHA are cardioprotective because they are potent antiarrhythmic agents, they improve vascular endothelial function, and lower blood pressure, platelet aggregation and serum triglyceride levels(3).
They also reduce the process of endothelial activation which leads to the onset of atheromatous plaque, while reducing the expression of adhesion molecules and monocyte binding to endothelial cells, as if such binding occurred, monocytes could infiltrate into the subendothelial space, where they would become macrophages, and in turn, foamy cells after phagocytosis of oxidized LDF, which would help build atheroma plaque(4).
In addition, EPA and DHA increase the production of nitric oxide, which is a gas with antiatherogenic effect: promotes vasodilation, reduces the expression of adhesion molecules on endothelium and inhibits platelet aggregation and proliferation of cells that form vascular smooth muscle (that contributes to the progression of atherosclerotic lesions) (4).
Given the important role Omega-3 has in the human body, it is necessary to ensure it has a good supply to maintain normal body structures and functions, and for the prevention and control of diseases, particularly coronary disorders.
Simopoulos, A. P. Evolutionary aspects of diet, the omega-6 omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 60, 502-507, doi:10.1016/j.biopha.2006.07.080 (2006).
Kang, J. X. & Leaf, A. Antiarrhythmic effects of polyunsa turated fatty acids. Recent studies. Circulation 94, 1774-1780 (1996).
Wijendran, V. & Hayes, K. C. Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr 24, 597-615, doi: 10.1146/annurev. nutr.24.012003.132106 (2004).
Brown, A. A. & Hu, F. B. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 73, 673-686 (2001).
- Neuringer, M., Connor, W. E., Lin, D. S., Barstad, L. & Luck, S. Biochemical and functional effects of prenatal and post-natal omega 3 fatty acid deficiency on retina and brain in rhe sus monkeys. Proc Natl Acad Sci USA 83, 4021-4025 (1986).